Functional characterization of substance P receptors on cultured human spinal cord astrocytes: synergism of substance P with cytokines in inducing interleukin-6 and prostaglandin E2 production - PubMed (original) (raw)
Functional characterization of substance P receptors on cultured human spinal cord astrocytes: synergism of substance P with cytokines in inducing interleukin-6 and prostaglandin E2 production
C Palma et al. Glia. 1997 Oct.
Abstract
Following brain injury, astrocytes express receptors for cytokines and neuropeptides and secrete several regulatory mediators that have a well established role in inflammation, immunity, and tissue development or repair. To elucidate the role of substance P (SP), a neurotransmitter peptide of the tachykinin family, in inducing astrocyte secretory activities, we have examined the expression of SP receptors and the functional consequences of their activation in cultured astrocytes from the human embryonic brain or spinal cord. Radioligand binding studies revealed that only one type of SP receptors, the high affinity NK-1 receptor, was present on human astrocytes and that spinal cord astrocytes expressed about 6 times as many SP binding sites as brain astrocytes. Following SP treatment, a substantial inositol phosphate formation was observed in spinal cord astrocytes only. Stimulation of spinal cord astrocytes with SP alone did not induce secretion of cytokines [interleukin-6 (IL-6), granulocyte-macrophage-CSF, macrophage chemoattractant protein-1 or leukemia inhibitory factor] or prostaglandin E2 (PGE2). Interestingly, however, SP selectively potentiated the inducing effect of IL-1beta on IL-6 and PGE2 secretion by spinal cord astrocytes without affecting the IL-1-beta-evoked secretion of other cytokines. SP also enhanced the small inducing effect of tumor necrosis factor-alpha (TNF-alpha) on IL-6 and PGE2 secretion and that of transforming growth factor-beta on PGE2 secretion. These results suggest that SP can enhance immunoregulatory and neurotrophic astroglial functions mediated by IL-6 and PGE2 by acting in concert with a set of cytokines whose cerebral expression has been reported during development and in a variety of diseases.
Similar articles
- [Correlation between activation of L5-S2 spinal cord astrocytes and effect of substance P in chronic prostatitis pain].
Zhang H, Liu LM, Lu GS, Xiong EQ, Li WB, Zhou ZS, Zhang JH, Pan JH, Chen ZW, Li LK, Yang Z, Song B. Zhang H, et al. Zhonghua Nan Ke Xue. 2009 Nov;15(11):1021-7. Zhonghua Nan Ke Xue. 2009. PMID: 20218316 Chinese. - Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha.
Aloisi F, Carè A, Borsellino G, Gallo P, Rosa S, Bassani A, Cabibbo A, Testa U, Levi G, Peschle C. Aloisi F, et al. J Immunol. 1992 Oct 1;149(7):2358-66. J Immunol. 1992. PMID: 1382099 - Macrophage migration inhibitory factor facilitates prostaglandin E2 production of astrocytes to tune inflammatory milieu following spinal cord injury.
Zhang Y, Zhou Y, Chen S, Hu Y, Zhu Z, Wang Y, Du N, Song T, Yang Y, Guo A, Wang Y. Zhang Y, et al. J Neuroinflammation. 2019 Apr 13;16(1):85. doi: 10.1186/s12974-019-1468-6. J Neuroinflammation. 2019. PMID: 30981278 Free PMC article. - Ciliary neurotrophic factor activates spinal cord astrocytes, stimulating their production and release of fibroblast growth factor-2, to increase motor neuron survival.
Albrecht PJ, Dahl JP, Stoltzfus OK, Levenson R, Levison SW. Albrecht PJ, et al. Exp Neurol. 2002 Jan;173(1):46-62. doi: 10.1006/exnr.2001.7834. Exp Neurol. 2002. PMID: 11771938 - Immunomodulatory and endocrine effects of deep brain stimulation and spinal cord stimulation - A systematic review.
Puk O, Jabłońska M, Sokal P. Puk O, et al. Biomed Pharmacother. 2023 Dec;168:115732. doi: 10.1016/j.biopha.2023.115732. Epub 2023 Oct 18. Biomed Pharmacother. 2023. PMID: 37862972 Review.
Cited by
- Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograft.
Palma C, Bigioni M, Irrissuto C, Nardelli F, Maggi CA, Manzini S. Palma C, et al. Br J Cancer. 2000 Jan;82(2):480-7. doi: 10.1054/bjoc.1999.0946. Br J Cancer. 2000. PMID: 10646908 Free PMC article. - Glutamate-mediated astrocyte-to-neuron signalling in the rat dorsal horn.
Bardoni R, Ghirri A, Zonta M, Betelli C, Vitale G, Ruggieri V, Sandrini M, Carmignoto G. Bardoni R, et al. J Physiol. 2010 Mar 1;588(Pt 5):831-46. doi: 10.1113/jphysiol.2009.180570. Epub 2010 Jan 18. J Physiol. 2010. PMID: 20083514 Free PMC article. - Inhibition of spinal 15-LOX-1 attenuates TLR4-dependent, nonsteroidal anti-inflammatory drug-unresponsive hyperalgesia in male rats.
Gregus AM, Buczynski MW, Dumlao DS, Norris PC, Rai G, Simeonov A, Maloney DJ, Jadhav A, Xu Q, Wei SC, Fitzsimmons BL, Dennis EA, Yaksh TL. Gregus AM, et al. Pain. 2018 Dec;159(12):2620-2629. doi: 10.1097/j.pain.0000000000001373. Pain. 2018. PMID: 30130298 Free PMC article. - A novel cell-cell signaling by microglial transmembrane TNFα with implications for neuropathic pain.
Zhou Z, Peng X, Hagshenas J, Insolera R, Fink DJ, Mata M. Zhou Z, et al. Pain. 2010 Nov;151(2):296-306. doi: 10.1016/j.pain.2010.06.017. Epub 2010 Jul 6. Pain. 2010. PMID: 20609516 Free PMC article. - Serum substance P levels are associated with severity and mortality in patients with severe traumatic brain injury.
Lorente L, Martín MM, Almeida T, Hernández M, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Jiménez A. Lorente L, et al. Crit Care. 2015 Apr 27;19(1):192. doi: 10.1186/s13054-015-0911-z. Crit Care. 2015. PMID: 25928056 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials